The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about our Panorama documentary, learn about our chart-topping research and find out how you can support our work.
Scientists have developed a new test – based on software used in criminology – to analyse immune system 'hotspots' in breast cancer tumours
An episode of Panorama focused entirely on the pioneering work of The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust aired on BBC One.
The ICR is striving to ensure all researchers have the same opportunities to develop their scientific careers, regardless of gender.
Genome analysis at our Tumour Profiling Unit – discovering cancer’s weaknesses
Pioneering phase I studies of new cancer drugs
How mouse 'avatars' could help tailor cancer treatments in head and neck cancers
Personalising treatments for patients on clinical trials
Developing new drugs for hard-to-treat childhood cancers
Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Your support can help us fight an often overlooked form of cancer, one that claims an increasingly large number of lives every year.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
In modern cancer treatment, are two drugs better than one?
Sandwiches, the pancreas and cancer’s bullying of healthy cells
Panorama’s behind the scenes glimpse at how science benefits cancer patients – and vice versa
Our scientists have developed a new test that predicts breast cancer outcome based on immune response http://t.co/oKIwEXeKpU